Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Medtronic Diabetes is a vital part of Medtronic plc, dedicated to transforming diabetes care by providing innovative solutions for people living with diabetes, their caregivers, and healthcare professionals. They are a global leader in insulin pump therapy, continuous glucose monitoring (CGM) systems, and smart insulin pen technology. Their focus is on developing integrated systems that automate insulin delivery, reduce the burden of diabetes management, and improve clinical outcomes for individuals with Type 1 and Type 2 diabetes requiring intensive insulin therapy.
Serves as the main hub for research and development, engineering, manufacturing, and commercial operations for Medtronic's global diabetes business group.
The Northridge campus is a significant site for Medtronic, featuring advanced R&D laboratories, manufacturing facilities for insulin pumps and CGMs, and administrative offices. It has a long history in diabetes technology development, stemming from the acquisition of MiniMed.
The work culture emphasizes innovation, patient-centricity, collaboration, and a commitment to quality. Employees are often driven by the mission to alleviate burden, restore health, and extend life for people with diabetes.
This location is historically significant as a birthplace of many pioneering diabetes technologies, including the first insulin pumps. It remains a critical center for Medtronic's continued innovation in the diabetes space.
Medtronic Diabetes, as part of Medtronic plc, has a significant global footprint. Its products are available in over 150 countries. Key functions such as research and development, manufacturing, sales, marketing, clinical support, and customer service are strategically located across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. This global presence enables Medtronic Diabetes to serve a diverse patient population and collaborate with healthcare systems worldwide to improve diabetes management.
18000 Devonshire Street
Northridge
California
USA
Address: 710 Medtronic Parkway NE, Minneapolis, MN 55432-5604
Key decision-making, corporate strategy, and shared services for all Medtronic businesses, including Diabetes, operating in the Americas and globally.
Address: Route du Molliau 31, 1131 Tolochenaz
Coordinates and supports Medtronic's diabetes business operations across the diverse EMEA market, ensuring products meet regional needs and regulatory standards.
Address: Road 31, Km 24.5, Juncos, PR 00777
A critical part of Medtronic's global supply chain for diabetes and other medical devices, ensuring product availability.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Medtronic Diabetes' leadership includes:
Medtronic Diabetes has been backed by several prominent investors over the years, including:
In the past 12-18 months, Medtronic has seen some broader portfolio leadership adjustments. Que Dallara continues to lead the Diabetes Operating Unit. No major new hires or exits specifically for the top-tier leadership of the Diabetes unit have been prominently announced recently, indicating stability in its direct leadership. Changes often occur at VP levels or within broader portfolio management.
Discover the tools Medtronic Diabetes uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Medtronic typically uses a standard corporate email format. The most common format is [first_initial][last_name]@medtronic.com or [first_name].[last_name]@medtronic.com.
firstname.lastname@medtronic.com
Format
john.smith@medtronic.com
Example
90%
Success rate
Medtronic News • May 20, 2024
Medtronic announced CE Mark for the Simplera™ Continuous Glucose Monitor (CGM) for children aged 2+. A pediatric study showed an overall MARD of 8.4%, indicating high accuracy. The sensor is disposable, all-in-one, and doesn't require fingersticks or overtape....more
Medtronic News • April 24, 2024
New real-world data from over 100,000 users of the MiniMed™ 780G system with Guardian™ 4 sensor in Europe showed users achieved an average Time in Range of 72.3% and Time in Tight Range (TITR) of 54.0%. Users on multiple daily injections (MDI) prior to system initiation saw an average A1c reduction of 1.4%....more
Medtronic News • January 8, 2024
Medtronic announced FDA approval for its MiniMed™ 780G system with Guardian™ 4 sensor. This advanced hybrid closed-loop system automatically adjusts and corrects sugar levels every 5 minutes, features meal detection technology, and requires no fingersticks when using SmartGuard™ technology....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Medtronic Diabetes, are just a search away.